11 / 20
Page 34
Notes:
allied
academies
Res Rep Gynaecol Obstet 2017 | Volume 1 Issue 4
November 02-03, 2017 | Chicago, USA
Embryology and In vitro Fertilization
World Congress on
The biotechnology of the human embryo
Vasil Galat
Northwestern University, USA
C
omplex approaches of embryo engineering, collectively
named the biotechnology of the human embryo, are
becoming an essential part of reproductive medicine. They
include preimplantation diagnosis; reproductive cloning;
interspecies chimaeras; artificial gametes; embryo editing;
mitochondrial transfer; stemcell technologies and iPSC. Their
impact on broad aspects of human health, reproductive and
therapeutic medicine will be discussed in this presentation.
Speaker Biography
Vasil Galat is an Assistant Professor in the Department of Pathology at Northwestern
University’s Feinberg School of Medicine and director of SMCRI Stem Cell Facility. He
has previously worked clinically in IVF programs and preimplantation diagnosis. He
has an extensive expertise in stem cell research and was the first to introduce human
embryonic stem cells harboring mutations specific for human diseases thus opening
a new field of research for developmental diseases currently known as disease in the
dish. He has published widely on subjects ranging from embryology to the directed
differentiation of iPSCs. The recent achievement of his lab in producing hematopoietic
cells from pluripotent cells provides a promising therapeutic tool for the cure of
cancers and some other blood-immune related disorders.
e:
v-galat@northwestern.edu